Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 31,958 | 30,552 | 27,970 | 52,483 | 27,198 |
| Cost of Goods | 7,101 | 8,803 | 7,039 | 6,921 | 5,738 |
| Gross Profit | 24,857 | 21,749 | 20,931 | 45,562 | 21,460 |
| Operating Expenses | 24,299 | 22,874 | 23,426 | 25,071 | 28,781 |
| Operating Income | 659 | -322 | -2,450 | 21,412 | -6,583 |
| Interest Expense | 881 | 896 | 895 | 884 | 884 |
| Other Income | 388 | 494 | 556 | 121 | 102 |
| Pre-tax Income | 166 | -724 | -2,789 | 20,649 | -7,365 |
| Income Tax | -81 | 62 | -9,483 | 13,303 | 368 |
| Net Income Continuous | 247 | -786 | 6,694 | 7,346 | -7,733 |
| Net Income | $247 | $-786 | $6,694 | $7,346 | $-7,733 |
| EPS Basic Total Ops | 0.02 | -0.06 | 0.48 | 0.52 | -0.55 |
| EPS Basic Continuous Ops | 0.02 | -0.06 | 0.48 | 0.52 | -0.55 |
| EPS Diluted Total Ops | 0.02 | -0.06 | 0.48 | 0.52 | -0.55 |
| EPS Diluted Continuous Ops | 0.02 | -0.06 | 0.48 | 0.52 | -0.55 |
| EPS Diluted Before Non-Recurring Items | 0.07 | 0.00 | 0.53 | N/A | N/A |
| EBITDA(a) | $2,823 | $2,087 | $-208 | $23,655 | $-4,387 |